JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB2216

Anti-HLA E antibody [MEM-E/02]

4

(6 Reviews)

|

(26 Publications)

Anti-HLA E antibody [MEM-E/02] (ab2216) is a mouse monoclonal antibody detecting HLA E in Western Blot, Flow Cytometry, IHC-P. Suitable for Human.

- KO validated for confirmed specificity
- Over 20 publications
- Trusted since 2002

View Alternative Names

HLA-6.2, HLAE, HLA-E, MHC class I antigen E

5 Images
Western blot - Anti-HLA E antibody [MEM-E/02] (AB2216)
  • WB

Lab

Western blot - Anti-HLA E antibody [MEM-E/02] (AB2216)

Lanes 1-4 : Merged signal (red and green). Green - ab2216 observed at 40 kDa. Red - loading control ab181602 observed at 36 kDa.

ab2216 Anti-HLA E antibody [MEM-E/02] was shown to specifically react with HLA E in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267080 (knockout cell lysate ab258452) was used. Wild-type and HLA E knockout samples were subjected to SDS-PAGE. ab2216 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated at room temperature for 2.5 hours at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-HLA E antibody [MEM-E/02] (ab2216) at 1/500 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

HLA-E knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human HLA-E (HLA E) knockout A549 cell line (<a href='/en-us/products/cell-lines/human-hla-e-hla-e-knockout-a549-cell-line-ab267080'>ab267080</a>)

Lane 3:

THP-1 cell lysate at 20 µg

Lane 4:

Jurkat cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution

Predicted band size: 40 kDa

Observed band size: 40 kDa

false

Flow Cytometry - Anti-HLA E antibody [MEM-E/02] (AB2216)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-HLA E antibody [MEM-E/02] (AB2216)

Overlay histogram showing HL60 cells stained with ab2216 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab2216, 1 μg/1x106 cells for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was Mouse IgG1 [ICIGG1] (ab91353, 2 μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA E antibody [MEM-E/02] (AB2216)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA E antibody [MEM-E/02] (AB2216)

IHC image of ab2216 staining in human tonsil formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab2216, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Western blot - Anti-HLA E antibody [MEM-E/02] (AB2216)
  • WB

Lab

Western blot - Anti-HLA E antibody [MEM-E/02] (AB2216)

Lanes 1-3 : Merged signal (red and green). Green - ab2216 observed at 40 kDa. Red - loading control ab52901 observed at kDa.

ab2216 Anti-HLA E antibody [MEM-E/02] was shown to specifically react with HLA E in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267231 (knockout cell lysate ab258454) was used. Wild-type and HLA E knockout samples were subjected to SDS-PAGE. ab2216 and Anti-beta Tubulin [EP1331Y] - Microtubule Marker (ab52901) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-HLA E antibody [MEM-E/02] (ab2216) at 1/500 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

HLA-E knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human HLA-E (HLA E) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-hla-e-hla-e-knockout-hek-293t-cell-line-ab267231'>ab267231</a>)

Lane 3:

THP-1 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution

Predicted band size: 40 kDa

Observed band size: 40 kDa

false

Western blot - Anti-HLA E antibody [MEM-E/02] (AB2216)
  • WB

Lab

Western blot - Anti-HLA E antibody [MEM-E/02] (AB2216)

Lanes 1-4 : Merged signal (red and green). Green - ab2216 observed at 40 kDa. Red - loading control ab181602 observed at 36 kDa.

ab2216 Anti-HLA E antibody [MEM-E/02] was shown to specifically react with HLA E in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267081 (knockout cell lysate ab258453) was used. Wild-type and HLA E knockout samples were subjected to SDS-PAGE. ab2216 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated at room temperature for 2.5 hours at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-HLA E antibody [MEM-E/02] (ab2216) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

HLA-E knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human HLA-E (HLA E) knockout A549 cell line (<a href='/en-us/products/cell-lines/human-hla-e-hla-e-knockout-a549-cell-line-ab267081'>ab267081</a>)

Lane 3:

THP-1 cell lysate at 20 µg

Lane 4:

Jurkat cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution

Predicted band size: 40 kDa

Observed band size: 40 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

MEM-E/02

Isotype

IgG1

Light chain type

unknown

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, IHC-P, WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human HLA-E.

P13747

Specificity

This antibody reacts with the denaturated heavy chain of human HLA-E. It does not cross-react with HLA-A, -B, -C or -G. Specifity of the antibody was confirmed on HLA-G/HLA-E Workshop(Victoria 2002).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5-10 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-HLA E antibody [MEM-E/02] (ab2216) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of HLA E?
Anti-HLA E [MEM-E/02] (ab2216) specifically detects a band for HLA E (UniProt: P13747) at a molecular weight of 40kDa.

Trusted by the scientific community
Anti-HLA E [MEM-E/02] (ab2216) was first used in a scientific publication in 2002 and has been cited over 20 times in peer-reviewed journals.

Reviewed by scientists
Anti-HLA E [MEM-E/02] (ab2216) has over 5 independent reviews from customers.

Specificity confirmed
The specificity of Anti-HLA E antibody [MEM-E/02] (ab2216) has been confirmed by Western blot testing in HLA-E Knockout A549 cell line, ab267231.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Purified from TCS. Purity >95% by SDS-PAGE.
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-classical major histocompatibility class Ib molecule involved in immune self-nonself discrimination. In complex with B2M/beta-2-microglobulin binds nonamer self-peptides derived from the signal sequence of classical MHC class Ia molecules (VL9 peptides - VMAPRT[V/L][L/V/I/F]L) (PubMed : 18083576, PubMed : 18339401, PubMed : 35705051, PubMed : 37264229, PubMed : 9754572). Peptide-bound HLA-E-B2M heterotrimeric complex primarily functions as a ligand for natural killer (NK) cell inhibitory receptor KLRD1-KLRC1, enabling NK cells to monitor the expression of other MHC class I molecules in healthy cells and to tolerate self (PubMed : 17179229, PubMed : 18083576, PubMed : 37264229, PubMed : 9486650, PubMed : 9754572). Upon cellular stress, preferentially binds signal sequence-derived peptides from stress-induced chaperones and is no longer recognized by NK cell inhibitory receptor KLRD1-KLRC1, resulting in impaired protection from NK cells (PubMed : 12461076). Binds signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules and acts as a ligand for NK cell activating receptor KLRD1-KLRC2, likely playing a role in the generation and effector functions of adaptive NK cells and in maternal-fetal tolerance during pregnancy (PubMed : 30134159, PubMed : 37264229, PubMed : 9754572). Besides self-peptides, can also bind and present pathogen-derived peptides conformationally similar to VL9 peptides to alpha-beta T cell receptor (TCR) on unconventional CD8-positive cytotoxic T cells, ultimately triggering antimicrobial immune response (PubMed : 16474394, PubMed : 20195504, PubMed : 30087334, PubMed : 34228645). Presents HIV gag peptides (immunodominant KAFSPEVIPMF and subdominant KALGPAATL epitopes) predominantly to CD8-positive T cell clones expressing a TRAV17-containing TCR, triggering HLA-E-restricted T cell responses (PubMed : 34228645). Presents mycobacterial peptides to HLA-E-restricted CD8-positive T cells eliciting both cytotoxic and immunoregulatory functions (PubMed : 20195504, PubMed : 35705051).. (Microbial infection) Viruses like human cytomegalovirus have evolved an escape mechanism whereby virus-induced down-regulation of host MHC class I molecules is coupled to the binding of viral peptides to HLA-E, restoring HLA-E expression and inducing HLA-E-dependent NK cell immune tolerance to infected cells.. (Microbial infection) May bind HIV-1 gag/Capsid protein p24-derived peptide (AISPRTLNA) on infected cells and may inhibit NK cell cytotoxicity, a mechanism that allows HIV-1 to escape immune recognition.. (Microbial infection) Upon SARS-CoV-2 infection, may contribute to functional exhaustion of cytotoxic NK cells and CD8-positive T cells (PubMed : 32859121). Binds SARS-CoV-2 S/Spike protein S1-derived peptide (LQPRTFLL) expressed on the surface of lung epithelial cells, inducing NK cell exhaustion and dampening of antiviral immune surveillance (PubMed : 32859121).
See full target information HLA-E

Publications (26)

Recent publications for all applications. Explore the full list and refine your search

International journal of biological sciences 21:5240-5257 PubMed40959273

2025

Senescent Tumoral HLA-E Reshapes Microenvironment through Impairing NK Cell-Dendritic Cell-T Cell Network in Malignant Pleural Effusion from Lung Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ying-Ming Tsai,Jen-Yu Hung,Yu-Yuan Wu,Hung-Pei Tsai,Kuan-Li Wu,Tai-Huang Lee,Hung-Hsing Chiang,Wei-An Chang,Hsiao-Chen Lee,Sheng-Feng Pan,Kai-Chien Chuang,Shu-Fang Jian,Ling-Yu Wu,Ya-Ling Hsu

Molecular immunology 172:56-67 PubMed38901180

2024

A monoclonal antibody that recognizes a unique 13-residue epitope in the cytoplasmic tail of HLA-E.

Applications

Unspecified application

Species

Unspecified reactive species

Elisha R Verhaar,Jin Gan,Susan Buhl,Ziao Li,Amir Horowitz,Hidde L Ploegh

Bioengineering (Basel, Switzerland) 10: PubMed36671682

2023

Histological Characterization of Class I HLA Molecules in Whole Umbilical Cord Tissue Towards an Inexhaustible Graft Alternative for Reconstructive Surgery.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Ying Yao,Dennis K Lee,Stephanie Jarvi,Marjan Farshadi,Minzhi Sheng,Sara Mar,Ori Nevo,Hon S Leong

Cancer cell 40:1027-1043.e9 PubMed36099881

2022

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Bérengère Salomé,John P Sfakianos,Daniel Ranti,Jorge Daza,Christine Bieber,Andrew Charap,Christian Hammer,Romain Banchereau,Adam M Farkas,Dan Fu Ruan,Sudeh Izadmehr,Daniel Geanon,Geoffrey Kelly,Ronaldo M de Real,Brian Lee,Kristin G Beaumont,Sanjana Shroff,Yuanshuo A Wang,Ying-Chih Wang,Tin Htwe Thin,Monica Garcia-Barros,Everardo Hegewisch-Solloa,Emily M Mace,Li Wang,Timothy O'Donnell,Diego Chowell,Ruben Fernandez-Rodriguez,Mihaela Skobe,Nicole Taylor,Seunghee Kim-Schulze,Robert P Sebra,Doug Palmer,Eleanor Clancy-Thompson,Scott Hammond,Alice O Kamphorst,Karl-Johan Malmberg,Emanuela Marcenaro,Pedro Romero,Rachel Brody,Mathias Viard,Yuko Yuki,Maureen Martin,Mary Carrington,Reza Mehrazin,Peter Wiklund,Ira Mellman,Sanjeev Mariathasan,Jun Zhu,Matthew D Galsky,Nina Bhardwaj,Amir Horowitz

Frontiers in molecular neuroscience 15:870085 PubMed35592112

2022

Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models.

Applications

Unspecified application

Species

Unspecified reactive species

David Labib,Zhen Wang,Priya Prakash,Matthew Zimmer,Matthew D Smith,Paul W Frazel,Lilianne Barbar,Maria L Sapar,Peter A Calabresi,Junmin Peng,Shane A Liddelow,Valentina Fossati

Cellular & molecular immunology 19:527-539 PubMed35039632

2022

Downregulated cytotoxic CD8 T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Applications

Unspecified application

Species

Unspecified reactive species

Heng Xu,Zhu Zhu,Jian Hu,Jiawei Sun,Yan Wo,Xianshu Wang,Hongzhi Zou,Bin Li,Yixin Zhang

The Journal of international medical research 49:3000605211047278 PubMed34617814

2021

Lesion human leukocyte antigen-E is associated with favourable prognosis for patients with oesophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yong-Fu Xu,Xue-Feng Du,Zhen-Yu Li,Zhe-Ping Fang,Fa-Biao Zhang

International journal of molecular sciences 22: PubMed34502547

2021

NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations.

Applications

Unspecified application

Species

Unspecified reactive species

Hana Jin,Hye Jung Kim

Clinical cancer research : an official journal of the American Association for Cancer Research 27:807-818 PubMed33122343

2020

Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Denis M Collins,Stephen F Madden,Nicola Gaynor,Dalal AlSultan,Marion Le Gal,Alex J Eustace,Kathy A Gately,Clare Hughes,Anthony M Davies,Thamir Mahgoub,Jo Ballot,Sinead Toomey,Darran P O'Connor,William M Gallagher,Frankie A Holmes,Virginia Espina,Lance Liotta,Bryan T Hennessy,Kenneth J O'Byrne,Max Hasmann,Birgit Bossenmaier,Norma O'Donovan,John Crown

HLA 96:197-201 PubMed32452158

2020

Human-porcine MHC-I homology allows for antibody cross-reactivity.

Applications

Unspecified application

Species

Unspecified reactive species

Nicole Forneris,Heather Levy,Christopher Burlak
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com